Identification of the Molecular Subtype and Prognostic Characteristics of Breast Cancer Based on Tumor‐Infiltrating Regulatory T Cells.

Background: T regulatory cells (Tregs) are essential for preserving immune tolerance. They are present in large numbers in many tumors, hindering potentially beneficial antitumor responses. However, their predictive significance for breast cancer (BC) remains ambiguous. This study aimed to explore g...

Descripción completa

Detalles Bibliográficos
Publicado en:Breast Journal Vol. 2025; pp. 1 - 15
Autores principales: Ma, Jianying, Hu, Gang, Kuang, Lianghong, Zhu, Zhongzhong, Wani, Imtiaz
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell 3/5/2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=183914231&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 183914231
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1075122X
        ET6
      jtl: Breast Journal
      issn: 1075122X
      maglogo: Y
    pubinfo:
      dt: 3/5/2025
      vid: 2025
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        183914231
        183914231
        183914231
        10.1155/tbj/6913291
        183914231
      ppf: 1
      ppct: 14
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Identification of the Molecular Subtype and Prognostic Characteristics of Breast Cancer Based on Tumor‐Infiltrating Regulatory T Cells.
      aug:
        au:
          Ma, Jianying
          Hu, Gang
          Kuang, Lianghong
          Zhu, Zhongzhong
          Wani, Imtiaz
        affil: Department of Breast Surgery,, Thyroid Surgery,, Huangshi Central Hospital,, Affiliated Hospital of Hubei Polytechnic University,, Huangshi, Hubei, China, hbpu.edu.cn
      sug:
        subj:
          Breast Neoplasms Prognosis
          T Lymphocytes
          Tumor Markers, Biological
          Human
          Gene Expression Profiling
          Algorithms
          Consensus
          Mutation
          Cluster Analysis
          Overall Survival
          Immune Checkpoint Inhibitors
          Immunotherapy
          Chemotherapy, Cancer
          Data Analysis Software
          Wilcoxon Rank Sum Test
          Pearson's Correlation Coefficient
          Kaplan-Meier Estimator
          Cox Proportional Hazards Model
          Funding Source
      ab: Background: T regulatory cells (Tregs) are essential for preserving immune tolerance. They are present in large numbers in many tumors, hindering potentially beneficial antitumor responses. However, their predictive significance for breast cancer (BC) remains ambiguous. This study aimed to explore genes associated with Tregs and develop a prognostic signature associated with Tregs. Methods: The gene expression and clinical data on BC were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. The integration of CIBERSORT and weighted correlation network analysis (WGCNA) algorithms was utilized to identify modules associated with Tregs. The consensus cluster algorithm was utilized to create molecular subtypes determined by genes associated with Tregs. Then, a prognostic signature associated with Tregs was constructed and its relationship to tumor immunity and the prognosis was evaluated. Results: The blue module genes exhibited the most significant correlation with Tregs, and 1080 genes related to Tregs were acquired. A total of 93 genes from the TCGA dataset were found to have a significant impact on patient prognosis. Samples from BC were categorized into two clusters by consensus cluster analysis. The overall survival, immune checkpoint genes, molecular subtype, and biological behaviors varied significantly between these two subtypes. A 10‐gene signature developed from differentially expressed genes between two subtypes demonstrated consistent prognostic accuracy in both TCGA and GEO datasets. It functioned as a standalone prognostic marker for individuals with BC. In addition, patients with low risk are more inclined to exhibit increased immune cell infiltration, TME score, and tumor mutation burden (TMB). Meanwhile, Individuals classified within the low‐risk group showed better responses to immunotherapies compared to their counterparts in the high‐risk group. Conclusions: The prognostic model derived from Tregs‐related genes could aid in assessing the prognosis, guiding personalized treatment, and potentially enhancing the clinical outcomes for patients with BC.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N